Write in a clean editor, then format for Influenza and Other Respiratory Viruses in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Influenza and Other Respiratory Viruses is a peer-reviewed journal published by Wiley, covering Influenza Virus Research Studies, Respiratory viral infections research, COVID-19 epidemiological studies.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Influenza and Other Respiratory Viruses 12 (3): 45–58.
Formats any DOI in Influenza and Other Respiratory Viruses style. No sign-up. |
| Publishes research in | Influenza Virus Research Studies Respiratory viral infections research COVID-19 epidemiological studies Pneumonia and Respiratory Infections SARS-CoV-2 and COVID-19 Research |
| ISSN | 1750-2640 |
| Citation impact (2-yr) | 3.65 |
| h-index | 95 |
| i10-index | 1,126 |
| Total citations | 50,594 |
| Article processing charge | $2,500 |
| Open access | Yes |
| Top institutions publishing here | Centers for Disease Control and Prevention |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Severe influenza infection represents a leading cause of global morbidity and mortality. Although influenza is primarily considered a viral infection that results in pathology limited to the respiratory system, clinical reports suggest that influenza infection is frequently associated with a number of clinical syndromes that involve organ systems outside the respiratory tract. A comprehensive MEDLINE…
BACKGROUND: A wide range of methods have been used for estimating influenza-associated deaths in temperate countries. Direct comparisons of estimates produced by using different models with US mortality data have not been published. OBJECTIVE: Compare estimates of US influenza-associated deaths made by using four models and summarize strengths and weaknesses of each model. METHODS: US…
There are two major classes of antivirals available for the treatment and prevention of influenza, the M2 inhibitors and the neuraminidase inhibitors (NAIs). The M2 inhibitors are cheap, but they are only effective against influenza A viruses, and resistance arises rapidly. The current influenza A H3N2 and pandemic A(H1N1)pdm09 viruses are already resistant to the…
AIM: The A/goose/Guangdong/1/96-like hemagglutinin (HA) genes of highly pathogenic avian influenza (HPAI) A(H5) viruses have continued to rapidly evolve since the most recent update to the H5 clade nomenclature by the WHO/OIE/FAO H5N1 Evolution Working Group. New clades diverging beyond established boundaries need to be identified and designated accordingly. METHOD: Hemagglutinin sequences deposited in publicly…
BACKGROUND: Estimates of influenza disease burden are broadly useful for public health, helping national and local authorities monitor epidemiologic trends, plan and allocate resources, and promote influenza vaccination. Historically, estimates of the burden of seasonal influenza in the United States, focused mainly on influenza-related mortality and hospitalization, were generated every few years. Since the 2010-2011…
